UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Platelet function testing in cardiovascular diseases

Circulation (New York, N.Y.), 2004-11, Vol.110 (19), p.e489-e493

Michelson, Alan D

2004

Volltextzugriff (PDF)

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Circulation (New York, N.Y.), 2005-12, Vol.112 (24), p.3738-3744

2005

Volltextzugriff (PDF)

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulation (New York, N.Y.), 2006-02, Vol.113 (5), p.671-678

2006

Volltextzugriff (PDF)

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin : Studies in baboons, human coronary intervention, and human acute myocardial infarction

Circulation (New York, N.Y.), 2001-09, Vol.104 (13), p.1533-1537

2001

Volltextzugriff (PDF)

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Circulation (New York, N.Y.), 2007-09, Vol.116 (13), p.1482-1487

2007

Volltextzugriff (PDF)

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-06, Vol.115 (24), p.3111-3120

2007

Volltextzugriff (PDF)

Body mass index and prognosis in patients with chronic heart failure : Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-08, Vol.116 (6), p.627-636

2007

Volltextzugriff (PDF)

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and Left ventricular systolic dysfunction : Results of the CHARM low-left ventricular ejection fraction trials

Circulation (New York, N.Y.), 2004-10, Vol.110 (17), p.2618-2626

2004

Volltextzugriff (PDF)

Effect of Candesartan on cause-specific Mortality in heart failure patients. The Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Circulation (New York, N.Y.), 2004-10, Vol.110 (15), p.2180-2183

2004

Volltextzugriff (PDF)

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2006-02, Vol.113 (7), p.986-994

2006

Volltextzugriff (PDF)

Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization

Circulation (New York, N.Y.), 2009-12, Vol.120 (25), p.2586-2596

2009

Volltextzugriff (PDF)

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

Circulation (New York, N.Y.), 2000-03, Vol.101 (9), p.1013-1018

2000

Volltextzugriff (PDF)

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway : A 700-patient study of aspirin resistance

Circulation (New York, N.Y.), 2006-06, Vol.113 (25), p.2888-2896

2006

Volltextzugriff (PDF)

Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children : Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial

Circulation (New York, N.Y.), 2008-01, Vol.117 (4), p.553-559

2008

Volltextzugriff (PDF)

Thrombophilia and pediatric stroke

Circulation (New York, N.Y.), 2010-04, Vol.121 (16), p.1795-1797

2010

Volltextzugriff (PDF)

Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report on a National Heart, Lung and Blood Institute Working Group

Circulation (New York, N.Y.), 2012-09, Vol.126 (13), p.1645-1662

2012

Volltextzugriff (PDF)

Effect of strenuous exercise on platelet activation state and reactivity

Circulation (New York, N.Y.), 1993-10, Vol.88 (4), p.1502-1511

1993

Volltextzugriff (PDF)

Arterial ischemic stroke in children: baby steps

Circulation (New York, N.Y.), 2006-11, Vol.114 (20), p.2094-2095

Michelson, Alan D

2006

Volltextzugriff (PDF)

Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation

Circulation (New York, N.Y.), 2001-09, Vol.104 (12), p.1374-1379

2001

Volltextzugriff (PDF)

Abstract 5770: The Platelet Activity After Clopidogrel Termination (PACT) Study

Circulation (New York, N.Y.), 2009-11, Vol.120 (suppl_18)

2009

Volltextzugriff (PDF)

Response to Letter Regarding Article, “Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial”

Circulation (New York, N.Y.), 2008-08, Vol.118 (7)

2008

Volltextzugriff (PDF)

Response to Letter Regarding Article, “Association of Cyclooxygenase-1–Dependent and –Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization”

Circulation (New York, N.Y.), 2010-08, Vol.122 (7)

2010

Volltextzugriff (PDF)

Response to Letter Regarding Article, “Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance”

Circulation (New York, N.Y.), 2007-01, Vol.115 (3)

2007

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Cardiac & Cardiovascular Systems
(44)
Cardiovascular System & Cardiology
(44)
Life Sciences & Biomedicine
(44)
Peripheral Vascular Disease
(44)
Science & Technology
(44)
Humans
(27)
Biological And Medical Sciences
(23)
Male
(19)
Medical Sciences
(19)
Animals
(17)
Cardiology. Vascular System
(17)
Female
(17)
Middle Aged
(15)
Aged
(13)
Blood And Lymphatic Vessels
(12)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(12)
Dogs
(12)
Pharmacology. Drug Treatments
(12)
Electrocardiography
(11)
Cardiac And Cardiovascular Systems
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Platelet function testing in cardiovascular diseases

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin : Studies in baboons, human coronary intervention, and human acute myocardial infarction

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Body mass index and prognosis in patients with chronic heart failure : Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and Left ventricular systolic dysfunction : Results of the CHARM low-left ventricular ejection fraction trials

Effect of Candesartan on cause-specific Mortality in heart failure patients. The Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Prasugrel Compared With High Loading-and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention : The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 Trial

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway : A 700-patient study of aspirin resistance

Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children : Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial

Challenges and priorities for research: a report from the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease

Thrombophilia and pediatric stroke

Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report on a National Heart, Lung and Blood Institute Working Group

Effect of strenuous exercise on platelet activation state and reactivity

Arterial ischemic stroke in children: baby steps

Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation

Abstract 5770: The Platelet Activity After Clopidogrel Termination (PACT) Study

Response to Letter Regarding Article, “Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial”

Response to Letter Regarding Article, “Association of Cyclooxygenase-1–Dependent and –Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization”

Response to Letter Regarding Article, “Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance”

Aktive Filter

Suchergebnisse filtern